$79.99
Modified GHRH analog. FDA-approved API (Egrifta) in research grade form. ≥99% purity — independently verified by Vanguard Laboratory, ISO/IEC 17025:2017 accredited. Batch-specific COA with every order. For research use only — not for human consumption.
This compound is in our testing pipeline and not yet available for purchase. Join the Be First waitlist for launch pricing and first access the moment it goes live.
Notify Me When This LaunchesDescription
Tesamorelin — Modified GHRH Analog
Tesamorelin is a synthetic analog of Growth Hormone Releasing Hormone consisting of the full 44-amino acid sequence of GHRH with a trans-3-hexenoic acid group at the N-terminus. The active pharmaceutical ingredient is approved by the FDA under the brand name Egrifta for HIV-associated lipodystrophy. Tesamorelin is among the most studied GHRH analogs in preclinical and clinical literature.
Specifications
- CAS Number: 218949-48-5
- Molecular Weight: 5135.9 Da
- Amino Acids: 44
- Form: Lyophilized Powder
- Purity: ≥99% — Vanguard Laboratory Verified
- Storage: -20°C Lyophilized / 4°C Reconstituted
- Volume: 3ml
Testing and Verification
Every batch independently tested by Vanguard Laboratory — ISO/IEC 17025:2017 accredited, A2LA Certificate #6377.01.
For Research Use Only — Not For Human Consumption.
Additional information
| Weight | 0.1 lbs |
|---|
Reviews
There are no reviews yet.